{"id":145824,"date":"2023-08-31T13:05:02","date_gmt":"2023-08-31T11:05:02","guid":{"rendered":"https:\/\/investmentbell.com\/?p=145824"},"modified":"2023-08-31T13:05:06","modified_gmt":"2023-08-31T11:05:06","slug":"sage-therapeutics-to-cut-40-of-jobs-after-depression-drug-setback","status":"publish","type":"post","link":"https:\/\/investmentbell.com\/fa\/news\/stocks\/sage-therapeutics-to-cut-40-of-jobs-after-depression-drug-setback\/","title":{"rendered":"Sage Therapeutics \u0628\u0631\u0627\u06cc \u06a9\u0627\u0647\u0634 40% \u0634\u063a\u0644 \u067e\u0633 \u0627\u0632 \u0634\u06a9\u0633\u062a \u062f\u0627\u0631\u0648\u06cc \u0627\u0641\u0633\u0631\u062f\u06af\u06cc"},"content":{"rendered":"<p>(\u0631\u0648\u06cc\u062a\u0631\u0632) - Sage Therapeutics \u0631\u0648\u0632 \u067e\u0646\u062c\u0634\u0646\u0628\u0647 \u0627\u0639\u0644\u0627\u0645 \u06a9\u0631\u062f \u06a9\u0647 \u0646\u06cc\u0631\u0648\u06cc \u06a9\u0627\u0631 \u062e\u0648\u062f \u0631\u0627 \u062d\u062f\u0648\u062f 40% \u06a9\u0627\u0647\u0634 \u0645\u06cc \u062f\u0647\u062f\u060c \u0686\u0646\u062f \u0647\u0641\u062a\u0647 \u067e\u0633 \u0627\u0632 \u0622\u0646 \u06a9\u0647 \u062a\u0646\u0638\u06cc\u0645 \u06a9\u0646\u0646\u062f\u0647 \u0633\u0644\u0627\u0645\u062a \u0627\u06cc\u0627\u0644\u0627\u062a \u0645\u062a\u062d\u062f\u0647 \u0627\u0632 \u062a\u0627\u06cc\u06cc\u062f \u062f\u0627\u0631\u0648\u06cc \u0622\u0646 \u0628\u0631\u0627\u06cc \u062f\u0631\u0645\u0627\u0646 \u0627\u062e\u062a\u0644\u0627\u0644 \u0627\u0641\u0633\u0631\u062f\u06af\u06cc \u0627\u0633\u0627\u0633\u06cc \u062e\u0648\u062f\u062f\u0627\u0631\u06cc \u06a9\u0631\u062f.<\/p>\n\n\n\n<p>\u0633\u0627\u0632\u0645\u0627\u0646 \u063a\u0630\u0627 \u0648 \u062f\u0627\u0631\u0648\u06cc \u0627\u06cc\u0627\u0644\u0627\u062a \u0645\u062a\u062d\u062f\u0647 (FDA) \u062f\u0631 \u0627\u0648\u0627\u06cc\u0644 \u0645\u0627\u0647 \u0627\u0648\u062a\u060c \u0642\u0631\u0635 \u0634\u0631\u06a9\u062a \u0648 \u0634\u0631\u06cc\u06a9 Biogen (NASDAQ:BIIB) \u0631\u0627 \u0628\u0631\u0627\u06cc \u0627\u0641\u0633\u0631\u062f\u06af\u06cc \u067e\u0633 \u0627\u0632 \u0632\u0627\u06cc\u0645\u0627\u0646 \u062a\u0627\u06cc\u06cc\u062f \u06a9\u0631\u062f\u060c \u0627\u0645\u0627 \u0622\u0646 \u0631\u0627 \u0628\u0647 \u0639\u0646\u0648\u0627\u0646 \u062f\u0631\u0645\u0627\u0646\u06cc \u0628\u0631\u0627\u06cc \u0627\u062e\u062a\u0644\u0627\u0644 \u0627\u0641\u0633\u0631\u062f\u06af\u06cc \u0627\u0633\u0627\u0633\u06cc \u06a9\u0647 \u0628\u0627\u0632\u0627\u0631 \u0628\u0633\u06cc\u0627\u0631 \u0628\u0632\u0631\u06af\u062a\u0631\u06cc \u0627\u0633\u062a\u060c \u0631\u062f \u06a9\u0631\u062f.<\/p>\n<div class=\"rate-now\"><span id=\"rate-mypost145824\"><\/span> <span id=\"rate-points\"> 0<\/span><\/div>\n\t\t\t<script type=\"text\/javascript\">jQuery('#rate-mypost145824').raty({\n\t\t\t\thalfShow : true,\n\t\t\t\thalf: true,readOnly: true,score: 0,\n\t\t\t\tpath: \"https:\/\/investmentbell.com\/wp-content\/plugins\/userpro-rating\/images\/\"\n\t\t\t\t});<\/script>","protected":false},"excerpt":{"rendered":"<p>(Reuters) &#8211; Sage Therapeutics said on Thursday it would cut its workforce by about 40%, weeks after the U.S. health regulator declined to approve its drug to treat major depressive disorder. The U.S. Food and Drug Administration (FDA) in early August approved the company and partner Biogen (NASDAQ:BIIB)&#8217;s pill for postpartum depression, but rejected it [&hellip;]<\/p>","protected":false},"author":13,"featured_media":145825,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":{"0":"post-145824","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-stocks"},"_links":{"self":[{"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/posts\/145824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/comments?post=145824"}],"version-history":[{"count":1,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/posts\/145824\/revisions"}],"predecessor-version":[{"id":145826,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/posts\/145824\/revisions\/145826"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/media\/145825"}],"wp:attachment":[{"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/media?parent=145824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/categories?post=145824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/investmentbell.com\/fa\/wp-json\/wp\/v2\/tags?post=145824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}